Type 2 Diabetes Medications to Know

Type 2 diabetes drugs are a core exam topic and split into several classes whose name endings are highly memorizable. Metformin sits at the top as the usual first-line agent, with newer classes added around it.

Study tip

Use the class suffixes: -gliptin for DPP-4 inhibitors (sitagliptin), -gliflozin for SGLT2 inhibitors (empagliflozin), and -glipizide/-glyburide for sulfonylureas. Metformin is the outlier worth memorizing on its own as first-line therapy.

Type 2 diabetes drug list (16)

By generic name, ordered by how commonly each is dispensed.

#Generic nameCommonly used for
3MetforminDiabetes (Type 2)
105SitagliptinDiabetes (Type 2)
106Sitagliptin / MetforminDiabetes (Type 2)
109DulaglutideDiabetes (Type 2)
110SemaglutideDiabetes (Type 2)
111TirzepatideDiabetes (Type 2)
243LinagliptinDiabetes (Type 2)
244CanagliflozinDiabetes (Type 2)
245Empagliflozin / LinagliptinDiabetes (Type 2)
246Empagliflozin / MetforminDiabetes (Type 2)
247PioglitazoneDiabetes (Type 2)
248GlimepirideDiabetes (Type 2)
249GlipizideDiabetes (Type 2)
250GlyburideDiabetes (Type 2)
251Exenatide ERDiabetes (Type 2)
252AlogliptinDiabetes (Type 2)

Study type 2 diabetes drugs for free

Turn this list into spaced-repetition flashcards. Create a free account and your progress saves automatically.

Frequently asked questions

What diabetes drug is usually learned first?
Metformin — it is the most common first-line type 2 diabetes medication and ranks at or near the top of popularity lists.
How do I keep the diabetes drug classes straight?
Lean on the suffixes: -gliptin (DPP-4 inhibitors), -gliflozin (SGLT2 inhibitors), and the sulfonylureas (glipizide, glyburide). Each ending maps to one class.

More drug categories

Educational study aid — not medical advice. Learn My Drugs is a memorization tool for pharmacy students, technicians, and exam prep. Drug names and uses on this page are simplified for studying and are not a substitute for professional judgment. For clinical, dosing, or safety information, consult the official label and a licensed professional.

Authoritative references: DailyMed, MedlinePlus, and the U.S. FDA.

Last reviewed: May 30, 2026.